• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,136
2,046
1,974
1,618
1,448

COUNTRY

1,006
787
244
217
175

CATEGORIES

  • 907
  • 188
  • 123
  • 326
    • 55
  • 461
  • 234
  • 265
  • 65
  • 78
  • 809
  • 1,436
  • 855
  • 24
  • 456
  • 1,325
  • 2,251
    • 89
    • 128
    • 71
    • 72
    • 44
    • 43
    • 21
    • 16
    • 20
    • 22
  • 25
  • 272
  • 49

PRICE

5,256
10,541
19,852
25,952

PUBLISHED

1,970
6,106
10,148
25,952

PRODUCT TYPE

21,877
1,951
972
894
164
37
21
19
10
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Analysing the Telemedicine Market in India Analysing the Telemedicine Market in India - Product Thumbnail Image

Analysing the Telemedicine Market in India

Executive Summary: The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations....

November 2014
FROM

Active Pharmaceutical Ingredients (API) Global Market - Forecast to 2020

Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect...

November 2014
FROM

Product and Pipeline Analysis of the Global Rheumatoid Arthritis Therapeutics Market

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and...

November 2014
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM

Jordan Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Continuing political instability in the region is having a detrimental impact on the country's economy and healthcare sector which is burdened with many Syrian refugees. The Jordanian government...

November 2014

Tanzania Pharmaceuticals and Healthcare Report Q1 2015

BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of raw materials increasingly expensive for the few remaining domestic pharmaceutical manufacturers. A tax regime...

November 2014
Japan Pharmaceuticals and Healthcare Report Q1 2015 Japan Pharmaceuticals and Healthcare Report Q1 2015 - Product Thumbnail Image

Japan Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovative pharmaceutical companies. This is driven by the country's rapidly ageing population, preference for branded...

November 2014
Bulgaria Pharmaceuticals and Healthcare Report Q1 2015 Bulgaria Pharmaceuticals and Healthcare Report Q1 2015 - Product Thumbnail Image

Bulgaria Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Large order increases from within the hospital sector and robust consumer demand will spur pharmaceutical sales growth in 2014 and 2015. However, external slowdown will begin to impact the...

November 2014

Algeria Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Against a backdrop of economic growth, the Algerian government commitment to expand and upgrade medical coverage and healthcare services in Algeria will translate in growing commercial opportunities...

November 2014

Italy Pharmaceuticals and Healthcare Report Q1 2015

BMI View: SN pharmaceutical expenditure will decline in 2014 - creating revenue pressures for drugmakers and pharmacies in Italy and increasing out-of-pocket costs for the population. The government...

November 2014

Hungary Pharmaceuticals and Healthcare Report Q1 2015

BMI View: We expect the decline in Hungary's pharmaceutical market to stabilise in 2015, although a challenging operating environment and regulatory burden will weigh on market growth. Our country risk...

November 2014

Romania Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push the burden further onto innovative drugmakers. With an improving macroeconomic outlook, increased government...

November 2014

Latvia Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions...

November 2014
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2015 Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2015 - Product Thumbnail Image

Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Côte d'Ivoire's healthcare sector will continue to be underfunded, making it difficult for the country to achieve its healthcare-related millennium development goals. This poses questions...

November 2014

Angola Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The Angolan government's initiatives to make healthcare more affordable, coupled with the municipalisation of health services, will lead to greater access to medical services and increase...

November 2014

Global Schizophrenia Therapeutics Market 2014-2018

About Schizophrenia Schizophrenia is a chronic brain disorder that severely affects the quality of life of a patient by disturbing the normal functioning of the brain. Psychotic symptoms and a diminished...

November 2014
FROM

Global Irritable Bowel Syndrome Market 2015-2019

About Irritable Bowel Syndrome Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease,...

November 2014
FROM

Global Pulmonary Drug Delivery Systems Market 2015-2019

About Pulmonary Drug Delivery Systems Pulmonary delivery of drugs leads to the deposition of drugs in the lungs and subsequent local or systemic therapeutic activity. The pulmonary route of administration...

November 2014
FROM
Global Oncology Biosimilars Market 2014-2018 Global Oncology Biosimilars Market 2014-2018 - Product Thumbnail Image

Global Oncology Biosimilars Market 2014-2018

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have...

November 2014
FROM

West Nile Virus Infections - Pipeline Review, H2 2014

West Nile Virus Infections - Pipeline Review, H2 2014 Summary This, ‘West Nile Virus Infections - Pipeline Review, H2 2014’, provides an overview of the West Nile Virus Infections’s therapeutic pipeline. This...

November 2014
FROM
Loading Indicator

Our Clients

Our clients' logos